REQUEST A DEMO
Total
USD $0.00
Search more companies

Jks Biomedical Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Jks Biomedical Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Jks Biomedical Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Petaling Jaya. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was established on January 15, 2009. From the latest financial highlights, Jks Biomedical Sdn. Bhd. reported a net sales revenue drop of 16.41% in 2022. Its’ total assets recorded a growth of 4.67%. Jks Biomedical Sdn. Bhd.’s net profit margin increased by 1.35% in 2022.

Headquarters
29, Jalan Pju 1A/15, Taman Perindustrian Jaya
Petaling Jaya; Selangor; Postal Code: 47301

Contact Details: Purchase the Jks Biomedical Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Jks Biomedical Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Jks Biomedical Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Jks Biomedical Sdn. Bhd. report to view the information.
Incorporation Date:
January 15, 2009
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Cymed Sdn. Bhd.
50%
Company Performance
Financial values in the chart are available after Jks Biomedical Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-16.41%
Total operating revenue
-16.41%
Operating profit (EBIT)
5.03%
EBITDA
4.15%
Net Profit (Loss) for the Period
3.54%
Total assets
4.67%
Total equity
14.91%
Operating Profit Margin (ROS)
1.85%
Net Profit Margin
1.35%
Return on Equity (ROE)
-2.66%
Debt to Equity Ratio
-16.52%
Quick Ratio
-0.14%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?